这是一篇来自已证抗体库的有关
人类 FGFR4的综述,是根据9篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合FGFR4 抗体。
FGFR4 同义词: CD334; JTK2; TKF
圣克鲁斯生物技术
小鼠 单克隆(A-10) | | 圣克鲁斯生物技术 FGFR4抗体(Santa Cruz Biotechnology, sc-136988)被用于被用于免疫印迹基因敲除验证在人类样本上 (图 s1). Cancers (Basel) (2020) ncbi |
小鼠 单克隆(A-10) | | 圣克鲁斯生物技术 FGFR4抗体(Santa Cruz, SC-136988)被用于被用于免疫印迹在人类样本上. J Thyroid Res (2014) ncbi |
小鼠 单克隆(A-10) | | 圣克鲁斯生物技术 FGFR4抗体(Santa Cruz, sc-136988)被用于被用于免疫印迹在仓鼠样本上. Protein Expr Purif (2014) ncbi |
艾博抗(上海)贸易有限公司
domestic rabbit 单克隆 | | 艾博抗(上海)贸易有限公司 FGFR4抗体(Abcam, ab178396)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 2k). Aging (Albany NY) (2021) ncbi |
小鼠 单克隆(5B5) | - 流式细胞仪; 人类; 1:100
- 免疫细胞化学; 人类; 1:100
| 艾博抗(上海)贸易有限公司 FGFR4抗体(Abcam, ab44971)被用于被用于流式细胞仪在人类样本上浓度为1:100 和 被用于免疫细胞化学在人类样本上浓度为1:100. PLoS ONE (2013) ncbi |
BioLegend
小鼠 单克隆(4FR6D3) | | BioLegend FGFR4抗体(BioLegen d, 324306)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi |
赛默飞世尔
domestic rabbit 多克隆 | | 赛默飞世尔 FGFR4抗体(Invitrogen, PA5-105531)被用于被用于免疫印迹在小鼠样本上 (图 8e). Sci Rep (2021) ncbi |
赛信通(上海)生物试剂有限公司
domestic rabbit 单克隆(D3B12) | | 赛信通(上海)生物试剂有限公司 FGFR4抗体(Cell Signalling, 8562)被用于被用于免疫印迹在人类样本上 (图 5b). Sci Rep (2016) ncbi |
domestic rabbit 单克隆(D3B12) | - 免疫组化-冰冻切片; 人类; 图 3
- 免疫印迹; 人类; 图 2
| 赛信通(上海)生物试剂有限公司 FGFR4抗体(Cell Signalling, 8562)被用于被用于免疫组化-冰冻切片在人类样本上 (图 3) 和 被用于免疫印迹在人类样本上 (图 2). Sci Rep (2015) ncbi |
Guo T, Gu C, Li B, Xu C. Dual inhibition of FGFR4 and BCL-xL inhibits multi-resistant ovarian cancer with BCL2L1 gain. Aging (Albany NY). 2021;13:19750-19759
pubmed 出版商
Homer Bouthiette C, Xiao L, Hurley M. Gait disturbances and muscle dysfunction in fibroblast growth factor 2 knockout mice. Sci Rep. 2021;11:11005
pubmed 出版商
Alijaj N, Moutel S, Gouveia Z, Gray M, Roveri M, Dzhumashev D,
et al. Novel FGFR4-Targeting Single-Domain Antibodies for Multiple Targeted Therapies against Rhabdomyosarcoma. Cancers (Basel). 2020;12:
pubmed 出版商
Milkiewicz M, Klak M, Kempińska Podhorodecka A, Wiechowska Kozlowska A, Urasinska E, Blatkiewicz M,
et al. Impaired Hepatic Adaptation to Chronic Cholestasis induced by Primary Sclerosing Cholangitis. Sci Rep. 2016;6:39573
pubmed 出版商
Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9
pubmed 出版商
Wunsch E, Milkiewicz M, Wasik U, Trottier J, Kempińska Podhorodecka A, Elias E,
et al. Expression of hepatic Fibroblast Growth Factor 19 is enhanced in Primary Biliary Cirrhosis and correlates with severity of the disease. Sci Rep. 2015;5:13462
pubmed 出版商
Tohyama O, Matsui J, Kodama K, Hata Sugi N, Kimura T, Okamoto K,
et al. Antitumor activity of lenvatinib (e7080): an angiogenesis inhibitor that targets multiple receptor tyrosine kinases in preclinical human thyroid cancer models. J Thyroid Res. 2014;2014:638747
pubmed 出版商
Sokolowska Wedzina A, Borek A, Chudzian J, Jakimowicz P, Zakrzewska M, Otlewski J. Efficient production and purification of extracellular domain of human FGFR-Fc fusion proteins from Chinese hamster ovary cells. Protein Expr Purif. 2014;99:50-7
pubmed 出版商
Zuliani T, Saiagh S, Knol A, Esbelin J, Dreno B. Fetal fibroblasts and keratinocytes with immunosuppressive properties for allogeneic cell-based wound therapy. PLoS ONE. 2013;8:e70408
pubmed 出版商